The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback